Recent advances in capillary electrophoresis-based proteomic techniques for biomarker discovery

Methods in Molecular Biology

Volumn 984, Issue , 2013, Pages 1-12

  Wang, Chenchen ^a   Fang, Xueping ^b   Lee, Cheng S ^a  

^a Bldg 142   (United States)

^b Calibrant Biosystems Inc   (United States)

Author keywords

Biomarker discovery; Capillary electrophoresis; Mass spectrometry; Reversed phase liquid chromatography; Tissue proteomics

Indexed keywords

BIOLOGICAL MARKER; PARAFFIN; PROTEOME; TUMOR MARKER;

ARTICLE; CANCER RECURRENCE; CANCER STEM CELL; CAPILLARY ELECTROPHORESIS; CAPILLARY ISOELECTRIC FOCUSING; CAPILLARY ZONE ELECTROPHORESIS; DISEASE ASSOCIATION; DISEASE COURSE; ELECTROSPRAY MASS SPECTROMETRY; GLIOBLASTOMA; HUMAN; MASS SPECTROMETRY; NONHUMAN; OVARY TUMOR; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; QUANTITATIVE ANALYSIS; SEPARATION TECHNIQUE; TIME; ANIMAL; ISOELECTRIC FOCUSING; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; NEOPLASM; REVERSED PHASE LIQUID CHROMATOGRAPHY; REVIEW;

ANIMALS; CHROMATOGRAPHY, REVERSE-PHASE; ELECTROPHORESIS, CAPILLARY; HUMANS; ISOELECTRIC FOCUSING; MASS SPECTROMETRY; NEOPLASMS; PARAFFIN EMBEDDING; PROTEOME; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

MLCS; MLOWN;

EID: 84880143528     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-296-4_1     Document Type: Article

References (43)

1. Drube J, Zurbig P, Schiffer E, Lau E, Ure B, Gluer S, Kirschstein M, Pape L, Decramer S, Bascands J-L, Schanstra JP, Mischak H, Ehrich JHH (2010) Urinary proteome analysis identifies infants but not older children requiring pyeloplasty. Pediatr Nephrol 25: 1673-1678
2. Theodorescu D, Schiffer E, Bauer HW, Douwes F, Eichhorn F, Polley R, Schmidt T, Schofer W, Zurbig P, Good DM, Coon JJ, Mischak H (2008) Discovery and validation of urinary biomarkers for prostate cancer. Proteomics Clin Appl 2: 556-570
3. Schiffer E, Vlahou A, Petrolekas A, Stravodimos K, Tauber R, Geschwend JE, Neuhaus J, Stolzenburg J-U, Conaway MR, Mischak H, Theodorescu D (2009) Prediction of muscleinvasive bladder cancer using urinary proteomics. Clin Cancer Res 15: 4935-4943
4. Schiffer E, Bick C, Grizelj B, Pietzker S, Schofer W (2012) Urinary proteome analysis for prostate cancer diagnosis: cost-effective application in routine clinical practice in Germany. Int J Urol 19: 118-125
5. Haubitz M, Good DM, Woywodt A, Haller H, Rupprecht H, Theodorescu D, Dakna M, Coon JJ, Mischak H (2009) Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody- associated vasculitis. Mol Cell Proteomics 8: 2296-2307
6. Zimmerli LU, Schiffer E, Zurbi P, Good DM, Kellmann M, Mouls L, Pitt AR, Coon JJ, Schmieder RE, Peter KH, Mischak H, Kolch W, Delles C, Dominiczak AF (2008) Urinary proteomic biomarkers in coronary artery disease. Mol Cell Proteomics 7: 290-298
7. von Zur Muhlen C, Schiffer E, Zuerbig P, Kellmann M, Brasse M, Meert N, Vanholder RC, Dominiczak AF, Chen YC, Mischak H, Bode C, Peter K (2009) Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patients. J Proteome Res 8: 335-345
8. Snell-Bergeon JK, Maahs DM, Ogden LG, Kinney GL, Hokanson JE, Schiffer E, Rewers M, Mischak H (2009) Evaluation of urinary biomarkers for coronary artery disease, diabetes, and diabetic kidney disease. Diabetes Technol Ther 11: 1-9
9. Jantos-Siwy J, Schiffer E, Brand K, Schumann G, Rossing K, Delles C, Mischak H, Metzger J (2009) Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease. J Proteome Res 8: 268-281
10. Kistler AD, Mischak H, Poster D, Dakna M, Wuthrich RP, Serra AL (2009) Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease. Kidney Int 76: 89-96
11. Good DM, Zurbig P, Argiles A, Bauer HW, Behrens G, Coon JJ, Dakna M, Decramer S, Delles C, Dominiczak AF, Ehrich JHH, Eitner F, Fliser D, Frommberger M, Ganser A, Girolami MA, Golovko I, Gwinner W, Haubitz M, Herget-Rosenthal S, Jankowski J, Jahn H, Jerums G, Julian BA, Kellmann M, Kliem V, Kolch W, Krolewski AS, Luppi M, Massy Z, Melter M, Neususs C, Novak J, Peter K, Rossing K, Rupprecht H, Schanstra JP, Schiffer E, Stolzenburg J-U, Tarnow L, Theodorescu D, Thongboonkerd V, Vanholder R, Weissinger EM, Mischak H, Schmitt-Kopplin P (2010) Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics 9: 2424-2437
12. Raedler TJ, Wittke S, Jahn H, Koessler A, Mischak H, Wiedemann K (2008) Capillary electrophoresis mass spectrometry as a potential tool to detect lithium-induced nephropathy: preliminary results. Prog Neuropsychopharmacol Biol Psychiatry 32: 673-678
13. Weissinger EM, Schiffer E, Hertenstein B, Ferrara JL, Holler E, Stadler M, Kolb H-J, Zander A, Zurbig P, Kellmann M, Ganser A (2007) Proteomic patterns predict acute graftversus- host disease after allogeneic hematopoietic stem cell transplantation. Blood 109: 5511-5519
14. Haselberg R, de Jong GJ, Somsen GW (2011) Capillary electrophoresis-mass spectrometry for the analysis of intact proteins 2007-2010. Electrophoresis 32: 66-82
15. Albalat A, Mischak H, Mullen W (2011) Clinical application of urinary proteomics/peptidomics. Expert Rev Proteomics 8: 615-629
16. Mischak H, Schanstra JP (2011) CE-MS in biomarker discovery, validation, and clinical application. Proteomics Clin Appl 5: 9-23
17. Metzger J, Chatzikyrkou C, Broecker V, Schiffer E, Jaensch L, Iphoefer A, Mengel M, Mullen W, Mischak H, Haller H, Gwinner W (2011) Diagnosis of subclinical and clinical acute T-cell-mediated rejection in renal transplant patients by urinary proteome analysis. Proteomics Clin Appl 5: 322-333
18. Zuberovic A, Wetterhall M, Hanrieder J, Bergquist J (2009) CE MALDI-TOF/TOF MS for multiplexed quantification of proteins in human ventricular cerebrospinalfluid. Electrophoresis 30: 1836-1843
19. Wiese S, Reidegeld KA, Meyer HE, Warscheid B (2007) Protein labeling by iTRAQ: a new tool for quantitative mass spectrometry in proteome research. Proteomics 7: 340-350
20. Wang W, Guo T, Rudnick PA, Song T, Li J, Zhuang Z, Zheng W, Devoe DL, Le CS, Balgley BM (2007) Membrane proteome analysis of microdissected ovarian tumor tissues using capillary isoelectric focusing/reversedphase liquid chromatography-tandem MS. Anal Chem 79: 1002-1009
21. Guo T, Wang W, Rudnick PA, Song T, Li J, Zhuang Z, Weil RJ, DeVoe DL, Lee CS, Balgley BM (2007) Proteome analysis of microdissected formalin-fixed and Paraffin-embedded tissue specimens. J Histochem Cytochem 55: 763-772
22. Liu H, Sadygov RG, Yates JR (2004) A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem 76: 4193-4201
23. Ishihama Y, Oda Y, Tabata T, Sato T, Nagasu T, Rappsilber J, Mann M (2005) Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 4: 1265-1272
24. Balgley BM, Wang W, Song T, Fang X, Yang L, Lee CS (2008) Evaluation of confidence and reproducibility in quantitative proteomics performed by a capillary isoelectric focusingbased proteomic platform coupled with a spectral counting approach. Electrophoresis 29: 3047-3054
25. Dai L, Li C, Shedden KA, Misek DE, Lubman DM (2009) Comparative proteomic study of two closely related ovarian endometrioid adenocarcinoma cell lines using cIEF fractionation and pathway analysis. Electrophoresis 30: 1119-1131
26. Hanrieder J, Zuberovic A, Bergquist J (2009) Surface modified capillary electrophoresis combined with in solution isoelectric focusing and MALDI-TOF/TOF MS: a gel-free multidimensional electrophoresis approach for proteomic profiling-exemplified on human follicularfluid. J Chromatogr A 1216: 3621-3628
27. Hood L (2003) Systems biology: integrating technology, biology, and computation. Mech Ageing Dev 124: 9-16
28. Aebersold R, Cravatt BF (2002) Proteomics- advances, applications and the challenges that remain. Trends Biotechnol 20: 1-2
29. An Y, Cooper JW, Balgley BM, Lee CS (2006) Selective enrichment and ultrasensitive identification of trace peptides in proteome analysis using transient capillary isotachophoresis/zone electrophoresis coupled with nano- ESI-MS. Electrophoresis 27: 3599-3608
30. Fang X, Yang L, Wang W, Song T, Lee C, Devoe D, Balgley B (2007) Comparison of Electrokinetics-Based Multidimensional Separations Coupled with Electrospray Ionization-Tandem Mass Spectrometry for Characterization of Human Salivary Proteins. Anal Chem 79: 5785-5792
31. Fang X, Wang W, Yang L, Chandrasekaran K, Kristian T, Balgley BM, Lee CS (2008) Application of capillary isotachophoresis-based multidimensional separations coupled with electrospray ionization-tandem mass spectrometry for characterization of mouse brain mitochondrial proteome. Electrophoresis 29: 2215-2223
32. Fang X, Balgley BM, Wang W, Park DM, Lee CS (2009) Comparison of multidimensional shotgun technologies targeting tissue proteomics. Electrophoresis 30: 4063-4070
33. Wolters DA, Washburn MP, Yates JR (2001) An automated multidimensional protein identification technology for shotgun proteomics. Anal Chem 73: 5683-5690
34. Jinawath N, Vasoontara C, Jinawath A, Fang X, Zhao K, Yap K-L, Guo T, Lee CS, Wang W, Balgley BM, Davidson B, Wang T-L, Shih I-M (2010) Oncoproteomic analysis reveals co-upregulation of RELA and STAT5 in carboplatin resistant ovarian carcinoma. PLoS One 5:e11198
35. Chen Z, Fadiel A, Xia Y (2006) Functional duality of merlin: a conundrum of proteome complexity. Med Hypotheses 67: 1095-1098
36. Huang K-C, Park DC, Ng S-K, Lee JY, Ni X, Ng W-C, Bandera CA, Welch WR, Berkowitz RS, Mok SC, Ng S-W (2006) Selenium binding protein 1 in ovarian cancer. Int J Cancer 118: 2433-2440
37. Chekhun VF, Lukyanova NY, Urchenko OV, Kulik GI (2005) The role of expression of the components of proteome in the formation of molecular profile of human ovarian carcinoma A2780 cells sensitive and resistant to cisplatin. Exp Oncol 27: 191-195
38. Smith-Beckerman DM, Fung KW, Williams KE, Auersperg N, Godwin AK, Burlingame AL (2005) Proteome changes in ovarian epithelial cells derived from women with BRCA1 mutations and family histories of cancer. Mol Cell Proteomics 4: 156-168
39. Duan Z, Foster R, Bell DA, Mahoney J, Wolak K, Vaidya A, Hampel C, Lee H, Seiden MV (2006) Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer. Clin Cancer Res 12: 5055-5063
40. Haura EB, Zheng Z, Song L, Cantor A, Bepler G (2005) Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer. Clin Cancer Res 11: 8288-8294
41. Chen L-F, Greene WC (2004) Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5: 392-401
42. Xu H, Yang L, Wang W, Shi S-R, Liu C, Liu Y, Fang X, Taylor CR, Lee CS, Balgley BM (2008) Antigen retrieval for proteomic characterization of formalin-fixed and paraffin-embedded tissues. J Proteome Res 7: 1098-1108
43. Balgley BM, Guo T, Zhao K, Fang X, Tavassoli FA, Lee CS (2009) Evaluation of Archival Time on Shotgun Proteomics of Formalin- Fixed and Paraffin-Embedded Tissues. J Proteome Res 8: 917-925